Biomarkers of endothelial dysfunction are elevated and related to prognosis in chronic heart failure patients with diabetes but not in those without diabetes

European Journal of Heart Failure

Volumn 10, Issue 4, 2008, Pages 380-387

  Kistorp, Caroline ^a   Chong, Aun Y ^b   Gustafsson, Finn ^c   Galatius, Søren ^a   Raymond, Ilan ^a   Faber, Jens ^a   Lip, Gregory Y H ^b   Hildebrandt, Per ^d  

^a GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^b UNIVERSITY DEPARTMENT OF MEDICINE   (United Kingdom)

^c Rigshospitalet   (Denmark)

^d ROSKILDE HOSPITAL   (Denmark)

Author keywords

Diabetes; Endothelial dysfunction; Prognosis

Indexed keywords

BIOLOGICAL MARKER; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; VON WILLEBRAND FACTOR;

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC PATIENT; ENDOTHELIAL DYSFUNCTION; FEMALE; HEART FAILURE; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; RECURRENCE RISK;

AGED; BIOLOGICAL MARKERS; DIABETES MELLITUS; E-SELECTIN; ENDOTHELIUM, VASCULAR; FEMALE; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; SURVIVAL ANALYSIS; VON WILLEBRAND FACTOR;

EID: 41449108061     PISSN: 13889842     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejheart.2008.02.012     Document Type: Article

References (32)

1. Fischer D., Rossa S., Landmesser U., Spiekermann S., Engberding N., Hornig B., et al. Endothelial dysfunction in patients with chronic heart failure is independently associated with increased incidence of hospitalization, cardiac transplantation, or death. Eur Heart J 26 (2005) 65-69
2. Gibbs C., Blann A., Watson R., and Lip G. Abnormalities of hemorheological, endothelial, and platelet function in patients with chronic heart failure in sinus rhythm: effects of angiotensin-converting enzyme inhibitor and beta-blocker therapy. Circulation 103 (2001) 1746-1751
3. Devaux B., Scholz D., Hirche A., Klovekorn W., and Schaper J. Upregulation of cell adhesion molecules and the presence of low grade inflammation in human chronic heart failure. Eur Heart J 18 (1997) 470-479
4. Chong A., Freestone B., Patel J., Lim H.S., Hughes E., Blann A.D., et al. Endothelial activation, dysfunction, and damage in congestive heart failure and the relation to brain natriuretic peptide and outcomes. Am J Cardiol 97 (2006) 671-675
5. Yin W., Chen J., Jen H., Chiang M.C., Huang W.P., Feng A.N., et al. The prognostic value of circulating soluble cell adhesion molecules in patients with chronic congestive heart failure. Eur J Heart Fail 5 (2003) 507-516
6. Ceriello A., Falleti E., Bortolotti N., Motz E., Cavarape A., Russo A., et al. Increased circulating intercellular adhesion molecule-1 levels in type II diabetic patients: the possible role of metabolic control and oxidative stress. Metabolism 45 (1996) 498-501
7. Matsumoto K., Sera Y., Nakamura H., Ueki Y., and Miyake S. Serum concentrations of soluble adhesion molecules are related to degree of hyperglycemia and insulin resistance in patients with type 2 diabetes mellitus. Diabetes Res Clin Pract 55 (2002) 131-138
8. Galatius S., Wroblewski H., Sorensen V., Bie P., Parving H., and Kastrup J. Endothelin and von Willebrand factor as parameters of endothelial function in idiopathic dilated cardiomyopathy: different stimuli for release before and after heart transplantation?. Am Heart J 137 (1999) 549-554
9. Suskin N., McKelvie R., Burns R., Latini R., Pericak D., Probstfield J., et al. Glucose and insulin abnormalities relate to functional capacity in patients with congestive heart failure. Eur Heart J 21 (2000) 1368-1375
10. From A., Leibson C., Bursi F., Redfield M.M., Weston S.A., Jacobsen S.J., et al. Diabetes in heart failure: prevalence and impact on outcome in the population. Am J Med 119 (2006) 591-599
11. Gustafsson I., Brendorp B., Seibaek M., Burchardt H., Hildebrandt P., Kober L., et al. Influence of diabetes and diabetes-gender interaction on the risk of death in patients hospitalized with congestive heart failure. J Am Coll Cardiol 43 (2004) 771-777
12. Galatius S., Gustafsson F., Nielsen P., Atar D., and Hildebrandt P. An integrated approach to diagnosis and therapeutic management of patients with systolic heart failure in the Copenhagen metropolitan area. Am Heart J 144 (2002) E2
13. Kistorp C., Galatius S., Gustafsson F., Faber J., Corell P., and Hildebrandt P. Prevalence and characteristics of diabetic patients in a chronic heart failure population. Int J Cardiol 100 (2005) 281-287
14. Raymond I., Pedersen F., Sørensen M., Green A., and Hildebrandt P. The Frederiksberg Heart Failure Study: rationale, design and methodology, with special emphasis on the sampling procedure for the study population and its comparison to the background population. Heart Drug 2 (2002) 167-174
15. Karl J., Borgya A., Gallusser A., Huber E., Krueger K., Rollinger W., et al. Development of a novel, N-terminal-proBNP (NT-proBNP) assay with a low detection limit. Scand J Clin Lab Invest Suppl 230 (1999) 177-181
16. Cockcroft D., and Gault M. Prediction of creatinine clearance from serum creatinine. Nephron 16 (1976) 31-41
17. Andersen T., Madsen M., Jorgensen J., Mellemkjoer L., and Olsen J. The Danish National Hospital Register. A valuable source of data for modern health sciences. Dan Med Bull 46 (1999) 263-268
18. Chin B., Chung N., Gibbs C., Blann A., and Lip G. Vascular endothelial growth factor and soluble P-selectin in acute and chronic congestive heart failure. Am J Cardiol 90 (2002) 1258-1260
19. Chong A., Freestone B., Lim H., Kistorp C., Gustafsson F., Hildebrandt P., et al. Plasma von Willebrand factor and soluble E-selectin levels in stable outpatients with systolic heart failure: the Frederiksberg heart failure study. Int J Cardiol 119 (2007) 80-82
20. Albertini J., Valensi P., Lormeau B., Aurousseau M.H., Ferriere F., Attali J.R., et al. Elevated concentrations of soluble E-selectin and vascular cell adhesion molecule-1 in NIDDM. Effect of intensive insulin treatment. Diabetes Care 21 (1998) 1008-1013
21. Otsuki M., Hashimoto K., Morimoto Y., Kishimoto T., and Kasayama S. Circulating vascular cell adhesion molecule-1 (VCAM-1) in atherosclerotic NIDDM patients. Diabetes 46 (1997) 2096-2101
22. Kowalska I., Straczkowski M., Szelachowska M., Kinalska I., Prokop J., Bachorzewska-Gajewska H., et al. Circulating E-selectin, vascular cell adhesion molecule-1, and intercellular adhesion molecule-1 in men with coronary artery disease assessed by angiography and disturbances of carbohydrate metabolism. Metabolism 51 (2002) 733-736
23. Ceriello A., Quagliaro L., Piconi L., Assaloni R., Da Ros R., Maier A., et al. Effect of postprandial hypertriglyceridemia and hyperglycemia on circulating adhesion molecules and oxidative stress generation and the possible role of simvastatin treatment. Diabetes 53 (2004) 701-710
24. Seligman B., Biolo A., Polanczyk C., Gross J., and Clausell N. Increased plasma levels of endothelin 1 and von Willebrand factor in patients with type 2 diabetes and dyslipidemia. Diabetes Care 23 (2000) 1395-1400
25. Chin B., Conway D., Chung N., Blann A., Gibbs C., and Lip G. Interleukin-6, tissue factor and von Willebrand factor in acute decompensated heart failure: relationship to treatment and prognosis. Blood Coagul Fibrinolysis 14 (2003) 515-521
26. Kannel W., Hjortland M., and Castelli W. Role of diabetes in congestive heart failure: the Framingham study. Am J Cardiol 34 (1974) 29-34
27. Shindler D., Kostis J., Yusuf S., Quinones M.A., Pitt B., Stewart D., et al. Diabetes mellitus, a predictor of morbidity and mortality in the Studies of Left Ventricular Dysfunction (SOLVD) Trials and Registry. Am J Cardiol 77 (1996) 1017-1020
28. Kistorp C., Faber J., Galatius S., Gustafsson F., Frystyk J., Flyvbjerg A., et al. Plasma adiponectin, body mass index, and mortality in patients with chronic heart failure. Circulation 112 (2005) 1756-1762
29. De J., Kooy A., Lehert P., Bets D., Wulffele M.G., Teerlink T., et al. Effects of short-term treatment with metformin on markers of endothelial function and inflammatory activity in type 2 diabetes mellitus: a randomized, placebo-controlled trial. J Intern Med 257 (2005) 100-109
30. Eurich D., Majumdar S., McAlister F., Tsuyuki R., and Johnson J. Improved clinical outcomes associated with metformin in patients with diabetes and heart failure. Diabetes Care 28 (2005) 2345-2351
31. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med 340 (1999) 115-126
32. Pigott R., Dillon L., Hemingway I., and Gearing A. Soluble forms of E-selectin, ICAM-1 and VCAM-1 are present in the supernatants of cytokine activated cultured endothelial cells. Biochem Biophys Res Commun 187 (1992) 584-589